Table 2.
The results of simple comparisons between patients with low and high fall scores
| Factor | Fall score <6 | Fall score ≥6 | p-value | ||
|---|---|---|---|---|---|
| n | 165 | 184 | |||
| Age (years) | Median [IQR] | 74.0 [70.0-79.0] | 82.0 [76.0-87.0] | <0.001 | |
| BMI (kg/m2) | Mean (SD) | 22.3 (3.5) | 21.7 (9.0) | 0.139 | |
| (%) | <18.5 | n (%) | 23 (13.9) | 36 (19.6) | 0.282 |
| 18.5-25 | n (%) | 107 (64.8) | 115 (62.5) | ||
| 25-30 | n (%) | 31 (18.8) | 31 (16.8) | ||
| 35< | n (%) | 4 (2.4) | 2 (1.0) | ||
| Anti-osteoporotic drugs | Any | n (%) | 68 (41.2) | 71 (38.6) | 0.662 |
| SERM | n (%) | 9 (5.5) | 4 (2.2) | 0.156 | |
| Bisphosphonate | n (%) | 42 (25.5) | 45 (24.5) | 0.901 | |
| Denosumab | n (%) | 10 (6.1) | 12 (6.5) | >0.999 | |
| Teriparatide | n (%) | 7 (4.2) | 10 (5.4) | 0.630 | |
| Estimated dietary calcium intake (g) | Median [IQR] | 13.8 (5.0) | 12.9 (5.1) | 0.074 | |
| BMD (mg/cm2) | Hip | Median [IQR] | 0.65 [0.58-0.72] | 0.58 [0.49-0.67] | <0.001 |
| Spine | median [IQR] | 0.78 [0.68-0.88] | 0.78 [0.65-0.88] | 0.684 | |
| Previous fracture | Any | n (%) | 96 (58.2) | 141 (76.6) | <0.001 |
| Spine | n (%) | 93 (56.4) | 133 (72.3) | 0.002 | |
| Hip | n (%) | 4 (2.4) | 16 (8.7) | 0.019 | |
| Serum calcium (mg/dL) | Mean (SD) | 9.4 (0.7) | 9.5 (0.5) | 0.104 | |
| eGFR (mL/min/1.73 m2) | Mean (SD) | 71.5 (17.1) | 67.8 (23.4) | 0.097 | |
| 25(OH)D (ng/mL) | Mean (SD) | 16.7 (6.8) | 14.6 (8.8) | 0.011 | |
| Grip strength (kg) | Median [IQR] | 18.00 [15.00-21.20] | 13.00 [9.30, 17.10] | <0.001 | |
| History of fall | n (%) | 7 (4.3) | 119 (65.0) | <0.001 | |
| Apprehension about fall | n (%) | 56 (33.9) | 134 (72.8) | <0.001 | |
IQR interquartile range; BMI body mass index; SD standard deviation; SERM selective estrogen receptor modulator; BMD bone mineral density; eGFR estimated glomerular filtration rate; 25(OH)D 25-hydroxyvitamin D